DecarineCAS# 54354-62-0 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 54354-62-0 | SDF | Download SDF |
| PubChem ID | 179640 | Appearance | Yellow powder |
| Formula | C19H13NO4 | M.Wt | 319.3 |
| Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 1-methoxy-[1,3]benzodioxolo[5,6-c]phenanthridin-2-ol | ||
| SMILES | COC1=C(C=CC2=C3C=CC4=CC5=C(C=C4C3=NC=C21)OCO5)O | ||
| Standard InChIKey | GJJFWGQGJJGJEO-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C19H13NO4/c1-22-19-14-8-20-18-12(11(14)4-5-15(19)21)3-2-10-6-16-17(7-13(10)18)24-9-23-16/h2-8,21H,9H2,1H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Decarine has high antibacterial activity against mycobacterial, gram-positive and gram-negative bacteria, and low cytotoxicity towards human macrophages. 2. Decarine inhibits fMLP/CB-induced elastase release with IC(50) values < or = 5.53 microg/mL. |
| Targets | Antifection |
Decarine Dilution Calculator
Decarine Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.1319 mL | 15.6593 mL | 31.3185 mL | 62.637 mL | 78.2963 mL |
| 5 mM | 0.6264 mL | 3.1319 mL | 6.2637 mL | 12.5274 mL | 15.6593 mL |
| 10 mM | 0.3132 mL | 1.5659 mL | 3.1319 mL | 6.2637 mL | 7.8296 mL |
| 50 mM | 0.0626 mL | 0.3132 mL | 0.6264 mL | 1.2527 mL | 1.5659 mL |
| 100 mM | 0.0313 mL | 0.1566 mL | 0.3132 mL | 0.6264 mL | 0.783 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Eriodictyol 7,3'-dimethyl ether
Catalog No.:BCN8105
CAS No.:54352-60-2
- 4beta-Hydroxywithanolide E
Catalog No.:BCN7572
CAS No.:54334-04-2
- Protopseudohypericin
Catalog No.:BCN2813
CAS No.:54328-09-5
- Amsacrine hydrochloride
Catalog No.:BCC4310
CAS No.:54301-15-4
- Ac-Gly-OH
Catalog No.:BCC2943
CAS No.:543-24-8
- 2',4'-Dihydroxy-3',6'-dimethoxydihydrochalcone
Catalog No.:BCN1421
CAS No.:54299-52-4
- (+)-Fluprostenol
Catalog No.:BCC7947
CAS No.:54276-17-4
- Stachyose trihydrate
Catalog No.:BCN8361
CAS No.:54261-98-2
- 3-Benzoylpyridine
Catalog No.:BCC8623
CAS No.:5424-19-1
- Cimaterol
Catalog No.:BCC6647
CAS No.:54239-37-1
- 1-Monopalmitin
Catalog No.:BCN7749
CAS No.:542-44-9
- Apilimod
Catalog No.:BCC5286
CAS No.:541550-19-0
- 4'-Methoxyacetoacetanilide
Catalog No.:BCC8712
CAS No.:5437-98-9
- BMS-538203
Catalog No.:BCC4136
CAS No.:543730-41-2
- 7-Hydroxy-5,8-dimethoxyflavanone
Catalog No.:BCN5722
CAS No.:54377-24-1
- N,N-Bis(2-hydroxyethyl)-p-phenylenediamine sulphate
Catalog No.:BCN8366
CAS No.:54381-16-7
- Lirinidine
Catalog No.:BCN8274
CAS No.:54383-28-7
- Palmitoylethanolamide
Catalog No.:BCC6828
CAS No.:544-31-0
- Myristic acid
Catalog No.:BCN8390
CAS No.:544-63-8
- Norcantharidin
Catalog No.:BCN1281
CAS No.:5442-12-6
- Capadenoson
Catalog No.:BCC1450
CAS No.:544417-40-5
- HIV-1 integrase inhibitor
Catalog No.:BCC1618
CAS No.:544467-07-4
- c-di-AMP
Catalog No.:BCC8054
CAS No.:54447-84-6
- MRS 1845
Catalog No.:BCC7198
CAS No.:544478-19-5
Amides and benzenoids from Zanthoxylum ailanthoides with inhibitory activity on superoxide generation and elastase release by neutrophils.[Pubmed:19128011]
J Nat Prod. 2009 Jan;72(1):107-11.
Five new compounds, ailanthamide (1), N-(4-methoxyphenethyl)-N-methylbenzamide (2), (2E,4E)-N-isobutyl-6-oxohepta-2,4-dienamide (3), 4-(4'-hydroxy-3'-methylbutoxy)benzaldehyde (4), and (E)-methyl 4-[4-(3-hydroxypropyl)phenoxy]-2-methylbut-2-enoate (5), and 17 known compounds have been isolated from the stem bark of Zanthoxylum ailanthoides. The structures were determined through spectroscopic and MS analyses. Compounds 1, 3, xanthyletin, Decarine, (+)-episesamin, (-)-hinokinin, and evofolin-B exhibited inhibition (IC(50) < or = 5.34 microg/mL) of superoxide anion generation by human neutrophils in response to formyl-l-methionyl-l-leucyl-l-phenylalanine/cytochalasin B (fMLP/CB). Compounds 1, xanthyletin, Decarine, and (+)-episesamin also inhibited fMLP/CB-induced elastase release with IC(50) values < or = 5.53 microg/mL.
Antibacterial benzofuran neolignans and benzophenanthridine alkaloids from the roots of Zanthoxylum capense.[Pubmed:22002848]
Planta Med. 2012 Jan;78(2):148-53.
Two new 2-arylbenzofuran neolignans and a new benzophenanthridine alkaloid, together with six known benzophenanthridine alkaloids, namely, Decarine, norchelerythrine, dihydrochelerythrine, 6-acetonyldihydrochelerythrine, tridecanonchelerythrine, and 6-acetonyldihydronitidine, have been isolated from the MeOH extract of the roots of Zanthoxylum capense. Their structures were elucidated by means of spectroscopic techniques including 2D NMR experiments. All the isolated compounds were evaluated for their in vitro antibacterial activity against gram-positive and gram-negative bacteria. Some compounds showed significant inhibitory activity against Staphylococcus aureus ATCC 6538 with MIC values ranging from 12.5 to 50 mug/mL.
New benzo[c]phenanthridine and benzenoid derivatives, and other constituents from Zanthoxylum ailanthoides: Effects on neutrophil pro-inflammatory responses.[Pubmed:24232457]
Int J Mol Sci. 2013 Nov 13;14(11):22395-408.
A new benzo[c]phenanthridine, oxynorchelerythrine (1), and two new benzenoid derivatives, methyl 4-(2-hydroxy-4-methoxy-3-methyl-4-oxobutoxy)benzoate (2) and (E)-methyl 4-(4-((Z)-3-methoxy-3-oxoprop-1-enyl)phenoxy)-2-methylbut-2-enoate (3), have been isolated from the twigs of Zanthoxylum ailanthoides, together with 11 known compounds (4-14). The structures of these new compounds were determined through spectroscopic and MS analyses. Among the isolated compounds, Decarine (4), (-)-syringaresinol (6), (+)-episesamin (8), glaberide I (9), (-)-dihydrocubebin (10), and xanthyletin (11) exhibited potent inhibition (IC50 values
Zanthoxylum capense constituents with antimycobacterial activity against Mycobacterium tuberculosis in vitro and ex vivo within human macrophages.[Pubmed:23337743]
J Ethnopharmacol. 2013 Mar 7;146(1):417-22.
ETHNOPHARMACOLOGICAL RELEVANCE: Zanthoxylum capense Thunb. (Rutaceae) is a medicinal plant traditionally used in Mozambique to treat tuberculosis. AIMS OF THE STUDY: The main aim of the study was to find antimycobacterial lead compounds from Zanthoxylum capense. Another goal was to provide scientific validation for the use of this plant in traditional medicine. METHODS AND MATERIALS: By bioassay-guided fractionation, 16 compounds were isolated and screened for their in vitro antimycobacterial activity against two different strains of Mycobacterium tuberculosis. Their in vitro cytotoxicity to human THP-1 macrophages was also assessed. The compounds with favourable selectivity index values (SI>10) were further investigated for their ability to inhibit the growth of Mycobacterium tuberculosis H37Rv in an intracellular macrophage model of infection. RESULTS: The best results were obtained for a benzophenanthridine alkaloid, Decarine (1), and an N-isobutylamide, N-isobutyl-(2E,4E)-2,4-tetradecadienamide (15), which showed high activity against Mycobacterium tuberculosis H37Rv (MIC of 1.6 mug/ml), and a low macrophage cytotoxicity (IC50>60 mug/ml), indicating considerable selective activity. The benzophenanthridine alkaloid 6-acetonyldihydronitidine (6) revealed cytotoxicity (IC50 1.7 mug/ml), despite the determined MIC of 6.2-12.5 mug/ml. In infected macrophages, Decarine (1) was able to reduce bacterial survival by almost two log units at a concentration of 6.2 mug/ml 5 days post-drug exposure. Compound 15 exhibited an intermediate activity at drug concentrations ranging from 6.2 to 25 mug/ml. CONCLUSIONS: The high antimycobacterial activity of Decarine found, both in vitro and ex vivo against mycobacteria, and the low cytotoxicity towards human macrophages indicate that it may be valuable as a lead scaffold for the development of anti-TB drugs.
